Logo

Wise and NYU Langone Health Publish the Results of Personal Zen App for Multiple Sclerosis in Frontiers in Neurology

Share this
Wise and NYU Langone Health Publish the Results of Personal Zen App for Multiple Sclerosis in Frontiers in Neurology

Wise and NYU Langone Health Publish the Results of Personal Zen App for Multiple Sclerosis in Frontiers in Neurology

Shots:

  • The clinical study evaluates Wise’s Personal Zen app in 35 patients with MS. The company is developing PTD with adaptive- personalized gameplay to address mental health needs in targeted populations like MS
  • The results demonstrated that Personal Zen app offers ABMT approach to reduce anxiety by 38.3% in adults and 20.1% in teenagers. Additionally- it showed 14.5% reduction in broad negative mood as measured by PANAS
  • The company is also studying the effects of its gamified ABMT on other patient populations to reduce anxiety in pregnant women and patients with alcohol use disorder

  | Ref: PR Newswire | Image: PR Newswire

Click here to­ read the full press release 

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions